Current Clinical Trials

Lekshmi R. Nath

Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham

India

Academic Editor

Biography

Dr. Lekshmi R. Nath is an Associate Professor in the Department of Pharmacognosy at the Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, India. She completed her PhD under the guidance of Dr. Ruby John Anto in the Cancer Research Program at the Rajiv Gandhi Centre for Biotechnology (RGCB), Trivandrum, Kerala, an autonomous research institution under the Department of Biotechnology, Government of India. Her groundbreaking PhD research on hepatocellular carcinoma led to four international patents (US, Canada, Japan, and South Korea) for her work on “Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma” (WO 2017208254 A1). Notably, the USFDA has granted orphan drug designation to Uttroside B for its potential as a chemotherapeutic agent against hepatocellular carcinoma. In a significant advancement, RGCB has signed an MOU with the Oklahoma Medical Research Foundation, USA, to facilitate the clinical translation of Uttroside B for liver cancer patients. Additionally, technology transfer has been executed with the multinational company Q Biomed.

Research Interest

Hepatocellular carcinoma & Phytomedicine -Cell death mechanism, Chemoprevention & Chemotherapy, Biomarker analysis in liver disorders